Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
BLA, Bruce, Chairman, Cozadd, crisantaspase, Enrylaze, half, Iannone, inactivation, join, Modification, occurrence, Robert, silent
Removed:
apnea, atonic, basket, Canopy, carefully, challenge, clonic, dispensing, Doose, efficacy, EMA, encephalopathy, epileptic, explore, extended, extraction, filled, fourth, generalized, holder, initiation, instituted, Joint, jointly, list, MAA, mandate, notwithstanding, onset, orexin, performing, physician, pitolisant, prescribing, produce, profile, randomized, reboxetine, referencing, seizure, settled, stipulation, tentatively, tonic, venetoclax, Western
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view